GlassScriptPhysician profile
Arun Kumar Nagabandi
NPI 1265797534
$13,234.95
in general payments reported to CMS, 2019-2025
43 companies · $1,100 in 2025
The $1,100 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,347 · 2020: $449 · 2021: $567 · 2022: $1,394 · 2023: $2,950 · 2024: $4,428 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,240 · Travel and Lodging: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,240.33 |
| Travel and Lodging | $2,238.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,027.17 | 2021-2025 | Corevalve Evolut R, Endurant Iis |
| Edwards Lifesciences Corporation | $3,730.50 | 2019-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,228.65 | 2019-2024 | Mitraclip, Cardiomems, Amplatzer |
| Boston Scientific Corporation | $549.61 | 2020-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $530.32 | 2020-2025 | |
| Shockwave Medical, INC | $299.93 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astellas Pharma US INC | $218.34 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $217.08 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.33 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $203.82 | 2021-2024 | Lifevest |
| Medtronic Vascular, INC. | $198.92 | 2019-2020 | |
| Pfizer INC. | $169.95 | 2019-2025 | |
| Amgen INC. | $167.05 | 2019-2022 | |
| Acist Medical Systems, INC. | $147.07 | 2019 | |
| Abbvie INC. | $146.64 | 2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Nagabandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.